Welcome to our dedicated page for Rainier Acquisition SEC filings (Ticker: RNAQU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Rainier Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Rainier Acquisition's regulatory disclosures and financial reporting.
Rainier Acquisition Corp (RNAQU) disclosed an initial statement of beneficial ownership for its Chief Executive Officer and director, Amusa Gbolahan. He holds 25,000 Class B ordinary shares, owned directly. Each Class B ordinary share is convertible into one Class A ordinary share at the holder's option or automatically upon the company’s initial business combination, and the Class B shares have no expiration date.
Rainier Acquisition Corp (RNAQU) filed an initial insider ownership report for Guy Barudin, who is identified as the company’s Chief Financial Officer. The filing is a Form 3, establishing him as a reporting person, and notes an attached Power of Attorney, but lists no reportable holdings or transactions.
Rainier Acquisition Corp (RNAQU) reported initial insider holdings for director and ten percent owner Jonas Grossman and for ten percent owner Ravenna 7 LLC. Grossman holds 25,000 Class B ordinary shares directly, each convertible into one Class A ordinary share. Ravenna 7 LLC holds 2,031,250 Class B ordinary shares indirectly attributable to Grossman, who is its sole managing member and disclaims beneficial ownership except to the extent of any pecuniary interest. The Class B shares are convertible on a one-for-one basis into Class A shares at the holder’s option or automatically at the time of the issuer’s initial business combination and have no expiration date.
Rainier Acquisition Corp (RNAQU) reported that director Isaac Manke holds 25,000 Class B ordinary shares directly. Each Class B ordinary share is convertible into one Class A ordinary share, for an underlying 25,000 Class A ordinary shares. The Class B ordinary shares have no expiration date and will automatically convert at the time of the company’s initial business combination or earlier at the holder’s option.
Rainier Acquisition Corp (RNAQU) director and reporting person Ugwumba Chidozie filed an initial statement of beneficial ownership. The filing reports direct ownership of 25,000 Class B ordinary shares, each convertible into one Class A ordinary share. The Class B ordinary shares have no expiration date, and no purchases or sales are reported.
Rainier Acquisition Corporation (RNAQU), a Cayman Islands–incorporated blank check company, is registering an initial public offering of 7,500,000 units at $10.00 per unit, for gross proceeds of $75,000,000, with a 45‑day over‑allotment option for up to 1,125,000 additional units. Each unit includes one Class A ordinary share and one‑quarter of one redeemable warrant exercisable at $11.50 per share. The company will deposit $75,000,000 (or $86,250,000 with full over‑allotment) into a U.S. trust account and has a 24‑month completion window to consummate an initial business combination, after which it will redeem 100% of public shares for cash, subject to conditions. Rainier intends to list its units, shares, and warrants on Nasdaq under the symbols “RNAQU”, “RNAQ”, and “RNAQW” and to focus on life sciences targets. The sponsor, Ravenna 7 LLC, holds 2,031,250 founder shares (Class B) and will purchase up to 200,000 private placement units, creating significant potential dilution for public shareholders and clear economic incentives to complete a deal. Members of the sponsor are affiliated with Chardan, the underwriter, triggering a FINRA Rule 5121 conflict of interest and requiring B. Riley Securities, Inc. to act as qualified independent underwriter.